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Abstract 
Computational modelling of the heart is rapidly advancing to the point of clinical utility. 
However, the difficulty of parameterizing and validating models from clinical data indicates 
that the routine application of truly predictive models remains a significant challenge. We 
argue there is significant value in an intermediate step towards prediction. This step is the 
use of biophysically based models to extract clinically useful information from existing 
patient data. Specifically in this paper we review methodologies for applying modelling 
frameworks for this goal in the areas of quantifying cardiac anatomy, estimating myocardial 
stiffness and optimizing measurements of coronary perfusion. Using these indicative 
examples of the general overarching approach, we finally discuss the value, ongoing 
challenges and future potential for applying biophysically based modelling in the clinical 
context.  
Keywords: Cardiac Computational models, Clinical biomarker, anatomy, myocardial 
stiffness, coronary flow.  
 Introduction 
The last 15 years has seen the intensification of efforts to develop clinically relevant 
computational models whose structure is directly linked to physiological mechanisms 
(Winslow et al. 2012). This work has been motivated by the objective of quantitatively 
predicting the behaviour of biological systems based on the integration of physiological 
understanding and clinical data.  Based on general philosophies first formally organized and 
articulated in the IUPS sponsored Physiome Project (Hunter & Borg 2003), the VPH initiative 
has since sharpened the clinical focus of this community (Smith et al. 2011).   
Within these programmes the heart has been, and arguably continues to be, the most 
advanced current exemplar of an integrated organ model for a number of reasons. 
Specifically, indicative of the relative simplicity of the heart is the well-characterized 
physiology of the cardiac system. This understanding has underpinned some of the very 
early exemplars of biophysically based models (DiFrancesco & Noble 1985) which, in turn, 
have provided a foundation on which many more complex frameworks have been 
developed (Clayton et al. 2011). Furthermore, while physiologically simple, the multi-physics 
function of the heart governed by nonlinear electrical-, mechanical- and fluid- dynamics has 
attracted a wide spectrum of researchers working at the interface between life and physical 
sciences. Finally, the links between health and heart function are direct and significant with 
cardiovascular disease remaining the number one cause of morbidity and mortality in the 
majority of western economies (Finegold et al. 2013). 
In parallel with, and independently of, advances in the fields of experimental physiology and 
computational modelling, the extraction of novel diagnostic biomarkers has been driven by 
progress in biomedical signal acquisition and analysis (see Fig. 1), more predominantly in 
 medical imaging (Lamata, Casero, et al. 2014). In many cases the speed of development of 
large classes of imaging modalities has been remarkable with spatial and temporal 
resolution rapidly improving. In many situations these improvements have driven the rapid 
translation of a modality from the domain of the basic scientist to that of the practicing 
clinician. Specific cardiac examples mean that measurements of cardiac wall motion, 
chamber flow patterns and coronary perfusion are increasingly being used to provide high-
resolution data sets for characterizing patients. 
In addition to being directly visualized and qualitatively analysed, these data are also being 
examined using tools that extract a range of metrics including examples such as cardiac 
strain maps, regional metabolism and chamber flow rates. The impact from these 
technologies has been both immediate and clinically significant. Biophysically based studies 
successfully providing clinical metrics range from the imposition of modelling based 
constraints to detailed computational models. Specific examples include the use of the large 
deformation assumption of incompressibility to regularise deformation fields in image 
registration algorithms (Shi et al. 2012)) or with increased complexity, compartmental 
models to quantify perfusion parameters from dynamic studies (Tofts et al. 1999), 
computational fluid dynamics to compute the virtual fractional flow reserve (Min et al. 2012), 
and the electro-mechanical models to predict the outcome of cardiac resynchronization 
therapy (Sermesant et al. 2012). 
However, in part because of the evidence-based focus of clinical medicine, the majority of 
extracted metrics continue to be analysed within phenomenological frameworks involving 
large patient cohorts. This practice arguably misses opportunities to extract the full value of 
information when integrated with established physiological understanding and patient-
specific contexts.   
 Figure 1 about here 
Efforts in parallel to apply biophysically based cardiac models in clinical contexts have also 
encountered other difficulties. In particular these include the critical development of a 
robust pipeline able to construct and solve models within clinical time scales. Embedded in 
this pipeline is also overcoming the challenge of deriving typically large nonlinearly related 
parameter sets from an individual’s clinical data that, while increasingly comprehensive, 
continues to include significant variability and noise. Thus, despite significant work of a 
highly motivated community and many examples of progress, to date, instances of direct 
application of cardiac models in the clinic remain scarce.  
This collective experience has revealed the size of a number of the challenges that remain to 
be overcome, and highlight that achieving this ultimate goal may still be some way off. 
However, we argue that this evidence in no way devalues the goal of developing 
biophysically based models of whole organs and ultimately complete organisms in clinical 
contexts. In fact, what is now emerging from this work is a valuable set of tools that are 
increasingly being productively applied in a middle ground between image analysis and 
predictive computational modelling. Specifically this includes the application of geometric, 
physics and biophysically based computational modelling approaches to extract information 
embedded in clinical images but not directly assessable. In cases where this information has 
a strong link to clinical outcome, even if it is phenomenological rather than purely 
mechanistic, it has the potential to be valuable as a clinical biomarker. Furthermore, in 
many cases the extracted information is also valuable for informing the parameterization of 
fully predictive biophysically based models and/or defining boundary conditions. Specific 
examples include the calculation of pressure gradients from imaged fluid motion (Lamata, 
 Pitcher, et al. 2014), the determination of patterns of electrical activation from high 
temporal resolution cardiac motion maps (Rappaport et al. 2007), the estimation of vessel 
wall stiffness from velocity of pressure pulse wave transmission (Gaddum et al. 2015), and 
the computation of the fractional flow reserve without the need for catheterised 
measurements(Min et al. 2012; Morris et al. 2013).    
Rather than document an exhaustive list, the scope of this review is to provide further 
tangible examples in more detail of this approach using the cardiac models developed 
within our group. Through this, our goal is to demonstrate the value of these methodologies 
and discuss the opportunities and challenges of model-based parameter extraction. We will 
start this review with the simplest case of a purely anatomically based analysis of cardiac 
geometry.  In the following section we will introduce the application of a physics model to 
extract mechanical parameters from cardiac motion data. Finally we will present a 
framework focused on capturing the biophysics across multiple scales to directly interpret, 
and ultimately optimise the acquisition of, the image data itself.   
Computational anatomy reveals hidden shape changes 
Cardiac remodelling refers to a change in size, shape or microstructure of our ventricles as a 
consequence of either exercise or a myocardial disease/injury. This is clinically 
demonstrated in Infarcted hearts that experience thinning and weakening of walls with 
necrosis, and they become larger, less elliptical and more spherical. In a progressive disease 
like heart failure, ventricles follow a similar remodelling path of larger size and sphericity 
(Helm et al. 2006; Fedak et al. 2005). Cardiac shape (remodelling) is thus an important 
indicator to stratify and monitor disease and therapy progression, and it is mainly 
characterized through changes in blood pool volume, sphericity or myocardial mass 57. 
 However, these metrics, although robust and well established, offer a limited 
representation of the variability of cardiac anatomy that is currently captured by 
conventional imaging modalities (US, MRI, CT).  
The core concepts used for the extraction of shape biomarkers are framed within the field 
of research called Computational Anatomy (Grenander & Miller 1998), and the main tool is 
the statistical shape model (Heimann & Meinzer 2009). The central approach is to use a 
consistent description of the shape of an organ across a population, with anatomical 
correspondence between the different subjects. Construction of statistical shape models 
from medical images requires two conceptual steps, the delineation (image segmentation) 
and the codification (mesh personalization through registration) of the anatomy of interest. 
In general, as a result of these two processes, the anatomy will be described by a large 
number of variables (mesh nodes or degrees of freedom), and techniques of dimensionality 
reduction (such as principal component analysis commonly used after a seminal work with 
2D images (Cootes et al. 1994)) are adopted to define the shape model (the average shape 
and the main modes of anatomical variation). As a result of this process, the anatomy of 
each case is described by a small set of shape coefficients that correspond to the modes of 
variation of the shape model: these are the potential new shape biomarkers. 
In essence, shape analysis is the study of the variability of shape in a given population. 
However, it is important to note that shape variability can also be caused by methodological 
limitations, such as human operator dependence at the acquisition stage, a lack of spatial 
resolution or image contrast, or a limited segmentation and meshing accuracy. Our recent 
advances have thus focused on the reduction of the impact of these limitations, proposing 
an automatic and robust mesh personalization strategy (Lamata, Sinclair, et al. 2014; 
 Lamata et al. 2011). The central approach in these studies is to regularise shape according to 
the assumption of a smooth ellipsoidal anatomy of the ventricles, formulated through 
meshes with high order interpolation and C1 continuity (the geometry and its derivatives are 
continuous) using cubic Hermite basis functions (see Fig. 2).   
 (Figure 2 about here) 
Progress in cardiac shape analysis is only possible due to the availability of images of 
sufficient resolution, quality and prevalence (Lamata, Casero, et al. 2014). 2D 
echocardiography is the most common in routine clinical practice, but it offers limited 
coverage of the anatomy with considerable inter-observer variability. For this reason 
Magnetic Resonance Image (MRI) is considered the gold standard for the quantification of 
cardiac morphology, and is thus the main focus of recent contributions in the field 46. 
Specifically the following two examples are constructed from short axis MRI, the most 
common image MRI study.  
In the specific example we focus on the application of statistical shape models to reveal 
anatomical changes in adulthood caused by a premature birth (Lewandowski et al. 2013). 
Shape metrics can predict the gestational age of an adult from the shape of its left ventricle 
with 93% specificity and 98% sensitivity (Gonzalez et al. 2015). Differences in this cohort 
were found in the six first modes of anatomical variation of the statistical shape model, 
encapsulating also subtle changes such as the relative position of the apex with respect to 
the ventricle that are missed by traditional metrics.  
In summary, computational models of cardiac anatomy reduce the impact of acquisition 
noise and segmentation errors, and enable clinicians to stratify subjects according to the 
 remodelling pattern, and therefore make more accurate predictions of cardiovascular risks 
in later stages of life.  
Mechanical models decouple diastolic biomarkers 
Ventricular filling (diastole) is as important as ejection (systole) for an adequate pump 
function of our heart. Nevertheless, characterization of the diastolic function in clinical 
guidelines is currently based on indirect surrogates such as the displacement of the mitral 
valve, or a ratio between early and late filling (Members et al. 2012). The motivation of this 
work is to propose novel tools to assess the fundamental mechanisms that rule diastolic 
filling, and then enable a better understanding of the aetiology of cardiac disease processes 
and a better stratification of patients.  
In a mechanical analysis of the ventricular chamber, an impaired diastolic function is caused 
by two main characteristics of the myocardium: its capacity to relax, and its stiffness. These 
two physiological parameters are coupled, and are difficult to assess in vivo. As a 
consequence, the criterion to diagnose diastolic dysfunction is guided by indirect surrogates 
and is subject to many limitations and controversies (Maeder & Kaye 2009). This is 
especially relevant for the management of heart failure with a preserved ejection fraction 
(HF-PEF), which affects half of patients with HF, and is a significant and growing clinical 
problem (Borlaug & Paulus 2011). The hypothesis is that computational models of cardiac 
mechanics can improve the assessment of diastolic performance by a direct estimation and 
uncoupling of the biomarkers of stiffness and relaxation. Then, the access to these 
fundamental metrics, and not indirect surrogates of diastolic filling, will enhance the 
management of diseases such as HF-PEF.  
 The core methodological concept applied to estimate the diastolic biomarkers is called data 
assimilation (Sermesant et al. 2006), and refers to the process of optimization of model 
parameters in order to reproduce the clinical information available. In our problem we have 
data of the deformation and the pressure of the left ventricle, and the model parameters 
are the material stiffness, the decaying active tension, and the reference configuration (the 
resting mechanical state - the  stress and strain free condition of the ventricle that is used as 
a reference in the mechanical simulation). In this approach, the simultaneous optimization 
of all unknowns with redundant information of several frames or heart beats achieves the 
uncoupling between stiffness and decaying tension, as described in 82. 
The estimation of stiffness and relaxation requires additional assumptions, since the 
number of unknowns is larger than the number of equations: each pair of pressure and 
deformation data represents an equation to be fulfilled, but with an additional unknown, 
the amount of remaining active tension at that time, in addition to the unknowns of 
stiffness and reference configuration. A common assumption is that there is no remaining 
active tension at the last diastolic frame (Xi et al. 2013; Wang et al. 2009), and it is also 
reasonable to consider the decaying active tension as a monotonically decaying function. 
With these two conditions all the parameters can be identified (Xi et al. 2013). 
A computational ventricular model to reproduce cardiac deformation and pressure can 
include a wide range of components, with different levels of physiological realism. The key 
aspects to consider are: a personalized geometry (reconstructed as described in the 
previous section), a material constitutive law to account for the passive mechanics 
(including non-linear and non-isotropic properties), a contractile decaying active tension, 
and a formulation of the mechanical equilibrium between forces (where different 
 assumptions can be taken, such as the incompressibility of the material, or a quasi-static 
formulation that neglects inertial effects). The model simulates an inflation of an elliptical 
geometry driven by the decay of the active tension and the increase of the loading (filling) 
pressure in the cavity. As a result, the deformation of the ventricle is predicted by defining 
the remaining components of the simulation, including the mechanical boundary conditions 
(see Fig.3).  
(Figure 3 about here) 
The core component in the estimation of parameters is the definition of the metric, the 
functional that compares the clinical data to the predicted inflation by the simulation. 
Common choices are the volume of the cavity (a single bulk metric, though robust), or the 
deformation field (much more detailed, but subject to errors finding the material point 
correspondence). Recent works have also explored the personalization constrained by 
velocities (thus including also mechanical inertial effects in the model), reporting an 
improved performance in the estimation of regional contractile parameters (Wong et al. 
2015). 
The current methodological limitation for the clinical translation is the need for catheterized 
pressure data(Xi et al. 2014). Research is also needed to uniquely identify material 
parameters, a problem that can be reduced by an adequate choice of the constitutive law 
(Hadjicharalambous et al. 2014; Nasopoulou et al. 2015). Other methodologically critical 
aspects are the choice of a mechanical reference configuration, and the correct temporal 
alignment of pressure and deformation data. Since the seminal work where materials 
stiffness was estimated from clinical data (Wang et al. 2009), computational models have 
been shown to be able to decouple active and passive mechanics, obtaining results that 
 correlate with the disease status of subjects (Xi et al. 2013), and to be more robust to offset 
errors in pressure recordings (Xi et al. 2014).  
Models reveal regions of perfusion defects 
The maintenance of coronary blood flow to cardiac tissue is not only critical for heart 
function but also remarkable. The modelling of coronary perfusion in the heart an 
inherently multi-physics problem requiring the integration of anatomical models with 
myocardial mechanics and coronary perfusion. A number of modelling efforts have 
developed anatomical models focused on representing coronary blood flow and/or the 
interaction with cardiac mechanics either in lumped parameter (Spaan et al. 1981) or 
anatomically detailed (Smith 2004) models (see Fig. 4). However, while informative in terms 
of physiology the complex and highly variable nature of coronary anatomy poses a 
significant challenge for developing personalized models that can be applied in the clinic.   
 (Figure 4 about here) 
Specifically, measuring flow below the largest coronary vessels introduces fundamental 
challenges. One modality used to overcome this issue is contrast-enhanced magnetic 
resonance perfusion imaging, in which injected contrast agents (CAs) provide an indication 
of regions that are perfused without having to determine flow at the vessel level. This 
approach has been shown to be effective, and combined with its non-invasive, non-ionising 
nature means perfusion protocols are being rapidly adopted in many clinical centres. 
However, in addition to the spatial temporal resolution issues, the transport and MR 
properties of these CAs means that their concentration (or contrast) is only a proxy for 
blood flow. In particular, the CAs are often freely diffusive, that is they diffuse through the 
 vessel walls into the cardiac tissue, and into regions that are under-perfused. In addition, 
the signal response curve is highly nonlinear, saturating after a threshold concentration. 
These effects confound absolute quantification of the blood flow and complicate the goal of 
developing model-based clinical metrics. 
 
One successful focus in the literature has been the use of models to assess myocardial 
perfusion reserve from clinical images. Myocardial perfusion reserve (MPR) is the ratio of 
baseline blood flow to hyperaemic flow, representing the ability of the heart to cope with 
increased oxygen demand. It is known that during exercise or under pharmaceutically 
induced stress, blood flow may increase by a factor of 3-4 (Cullen et al. 1999) and therefore 
a measured MPR of 3-4 indicates a healthy condition. Extracting a quantitative estimate of 
MPR from MR perfusion imaging therefore provides a useful biomarker with which to 
diagnose and assess the functional severity of a coronary stenosis.  
 
Several different methods have been proposed in the literature for calculating this metric, 
which designate it as either MPR or myocardial perfusion reserve index (MPRI). An early 
theoretical treatment of CA transport in the coronary circulation was the central volume 
principle analysis by Zierler, which showed that , under the assumption of constant flow, 
estimates of flow and volume could be extracted from a concentration time profile (Zierler 
1962). Jerosch-Herold et al (Jerosch-Herold et al. 1998) built on the central volume principle 
to represent each voxel in the myocardium by a transfer function, in this case a Fermi 
function. An estimate of myocardial blood flow was then obtained by performing a 
 deconvolution of the perfusion signal and the input signal taken from the left ventricular 
cavity. This was done under both rest and stress conditions to directly calculate an MPRI. 
 
Cullen et al (Cullen et al. 1999) used an ordinary differential compartment model to 
represent the flux of CA through the myocardium (see Tofts et al (Tofts et al. 1999) for 
further refinements of these models). From the measured signals they estimated a 
parameter K, which is proportional to perfusion, and which, under certain assumptions, can 
be used to calculate a ratio that is representative of MPR.  Nagel et al. (Nagel et al. 2003), 
building on the insight that signal upslope relates to flow (Al-Saadi et al. 2000), proposed 
that an MPRI could be more simply computed via the ratio of normalized peak signal 
upslopes taken under rest and stress conditions. Though advocating this method for its 
simplicity, Nagel et al. concede that the freely diffusive behaviour of the CA appeared to 
confound the index. Furthermore, Jerosch-Herold(Jerosch-Herold et al. 2004) demonstrated 
that this method of calculating MPRI underestimates flow reserves in healthy cases when 
compared with other accepted quantitative modalities such as PET. They verified this 
behaviour computationally using MMID4, the multi-path, multi-indicator, four-region organ 
model developed by Bassingthwaighte (now part of the JSIm environment (Butterworth et 
al. 2013)).  
(Figure 5 about here) 
Therefore to investigate the metric’s sensitivity to freely diffusive CA properties, a porous 
medium model of CA transport in the myocardium(Cookson et al. 2014) is used to perform a 
parameter space study. This more complex approach treats the blood flow (Cookson et al. 
 2012; Chapelle et al. 2010; Michler et al. 2013), CA transport (Cookson et al. 2014; Sourbron 
2014; Nolte et al. 2013), and imaging physics (Cookson et al. 2014) separately. Specifically, 
porous medium models – which can represent spatially heterogeneous tissue properties 
and blood flow – form the input to a scalar transport model of a freely diffusive CA through 
the blood and extra-cellular space, represented schematically in Fig. 5. The porous flow 
models are parameterised as a continuum using a volume-averaging of discrete vessel 
characteristics (Hyde et al. 2012; Hyde et al. 2014). The CA concentration given by the 
transport model is then post-processed using an empirically derived signal response 
function (Ishida et al. 2010). 
 
The effect of the freely diffusive behaviour is demonstrated in the point-wise perfusion 
signal traces extracted from the model shown in Figure 6. Comparing results for a blood 
pool CA in Figure 6c and a freely diffusive CA in Figure 6d, effect of the trans-vascular 
diffusion is to extend the signal’s tail and slow the decay rate, due to the storage of CA in 
the extra-cellular space and its subsequent slow clearance. Consequently the concentration 
and signal are no longer directly related to the blood flow at a given point in time. Figure 7 
shows the variation of these signals’ upslope with changing transport properties of the CA. 
Specifically the Peclet number, Pe, which characterises the extent to which transport of the 
CA occurs through blood flow relative to molecular diffusion, and the Damköhler number, 
Da, which describes how quickly the CA diffuses into the extravascular space relative to 
transport by the blood velocity. Under a stress protocol, when velocity may triple, Pe will 
triple, while Da reduces by a third. 
(Figure 6 about here) 
 (Figure 7 about here) 
These results show that a CA with Da in the range 0.1 to 10 will be most sensitive for 
calculating MPRI. For Da < 0.1, the change in upslope is due solely to changes in Pe, as 
indicated by the arrows in Fig 7. However, for Da > 10, the increase in upslope due to 
increasing Pe is counteracted by the reduction due to decreasing Da, rendering MPRI 
insensitive and susceptible to noise in this region. This implies that some degree of freely 
diffusive behaviour may actually be favourable when calculating MPRI, making the metric 
more sensitive. Modelling therefore provides a valuable contribution to evaluating the 
suitability of a particular CA for use with a desired image analysis metric. 
 
As these models and the data assimilation pipeline continue to mature, including the 
introduction of a poroelastic formulation of the CA transport model (Cookson et al. 2012; 
Cookson et al. 2015; Lee et al. 2014) that captures perfusion, mechanics, and perfusion 
imaging in the beating heart, it will be possible to create realistic simulations of clinical 
perfusion images. Using the perfusion simulation as a gold standard reference of the 
underlying blood flow, the imaging protocol can be computationally optimized to provide 
the best representation of this flow. Potential applications where this extra spatial and 
physical fidelity will prove crucial include refining perfusion gradient based analysis 
(gradientograms) (Hautvast et al. 2011) and directly comparing 2D perfusion imaging with 
3D (Motwani et al. 2014). 
 
Discussion 
 It can be argued that the interpretation of clinical data from the perspective of a model is as 
old as medical practice itself. By “model” here we refer to the representation of our 
understanding of human physiology. The step taken by the VPH community is the 
deployment of computational technologies to expand the integrative scope of these 
models, thus enabling quantitative analysis of complex data across multiple scales. The 
examples presented above are indicative of this type of significantly wider community effort 
to translate computational modelling of the heart into the clinic. In this paper we have 
argued that a key staging point in producing ultimately predictive models is first the use of 
these frameworks to extract more robust and accurate diagnostic biomarkers, focusing thus 
the scope on the explanatory rather than predictive application of models. The value in 
pursuing this goal is in more rapidly delivering clinically useful tools while simultaneously 
developing a foundation from which to extend the same modelling techniques for 
prediction.  
However, while in many ways using models to derive biomarkers is a less ambitious 
objective, a number of central challenges remain. Specifically, the extraction of a novel 
biomarker requires the balancing of model complexity with the quality and availability of 
data. Historically biophysically based cardiac models have often embedded detailed 
representations of established mechanisms that are in tension with the identifiability of 
model parameters given the available resolution and accuracy of clinical data (Audoly et al. 
2001; Kirk et al. 2013). This means that there remain highly sophisticated modelling 
frameworks that continue to be too detailed to be directly translated to a clinical context. 
The reason for this mismatch between complexity and clinically available data is that often 
models have been developed as part of controlled ex vivo or animal experimental studies 
 (Niederer et al. 2009; Li et al. 2010).  This approach has provided a solid foundation to 
advance our knowledge of physiology (see vertical arrow in Fig. 1). However, it is important 
to note that clinical translation requires the reduction of the complexity of the modelling 
framework so that it encapsulates the behaviour of physiological variables that are 
observable or inferable from clinical data alone. As argued in (Garny et al. 2005), the ideal 
model is as simple as possible, and as complex as necessary for the particular question 
raised. This principle is demonstrated specifically in the example of the estimation of 
diastolic biomarkers, which is limited by the low identifiability of the material constitutive 
parameters (Xi et al. 2013) but where the choice of an adequate model for the constitutive 
relationship can alleviate the impact of this limitation (Hadjicharalambous et al. 2014).   
It is also important to note that the extraction of diagnostic biomarkers does not require a 
perfect match between model and data. As outlined above both model and data have 
limitations and as such they are both sources of uncertainty about the physiological variable 
that is being assessed. Analysis of the sensitivity of results to model assumptions and to 
noise and artefacts in the data, and how the uncertainty is propagated(Pathmanathan & 
Gray 2013), are critical steps for the efficacy of novel biomarkers. As argued, the key is to 
choose the right model for the clinical question, with the addition of minimal complexity. 
There is significant evidence that you do not need a fully realistic, validated and predictive 
model to make a clinical impact. Even a very simplified model can provide significant 
diagnostic value, such as the non-invasive estimation of the pressure drop through a 
stenosed cardiac valve through the peak blood velocity applying the Bernoulli 
principle(Firstenberg et al. 2000).  
 Given the often practical and sometimes ethical constraints around collecting clinical data, 
testing and validating novel ideas and methods to extract clinical biomarkers through 
computational models is often difficult. In this context, a valuable first step is the testing of 
a technique through in silico experiments. If successful, an initial proof of concept with 
simulation results is provided, and additional insights about the requirements in data 
availability and quality are generated. An example is the definition of the number of frames 
required to constrain the identification of myocardial stiffness (Augenstein et al. 2005), and 
the possibility to reveal regional myocardial stiffness by recording a number of heart beats 
(Xi et al. 2011). However, it is important to note that such a result, while necessary, is far 
from being a sufficient finding of positive evidence for working with real clinical data.  
As argued above, computational models also have the capability to unveil metrics that 
otherwise are not measurable directly from the data. Stiffness or permeability as described 
above are extracted when clinical data is explained through a fundamental physics law 
formulated in a model. This brings the potential of an additional mechanistic understanding 
of the disease process, offering a closer link to the pathophysiological causes. The 
opportunities here are clear but again there are also risks. The incorporation of sparse 
sources of data also introduces errors in the temporal synchrony or spatial alignment of the 
different pieces. This means that the new model-driven biomarkers can be very sensitive to 
these errors, and thus reduce any potential clinical translation. Robust and reliable 
biomedical signal analysis algorithms are needed to mitigate this risk. 
A collateral benefit of the approach outlined in this study is that the disagreement between 
even incomplete/simplified models and noisy/limited data presents opportunities to gain 
additional insights. Specifically, a mismatch between the model and the data provides the 
 ability to challenge assumptions, revealing the relevance of a model component not 
included, and to eventually improve the realism of the model (Smith et al. n.d.). This 
mismatch can also originate in the data limitations guiding researchers and/or clinicians to 
optimise acquisition protocols, to reconsider the adoption of better constraints or 
assumptions to reconstruct or extract the relevant information, and to eventually improve 
the quality of the data. The interaction between experiment and simulation is important for 
the generation of advances and novel insights. An example of this process was the inclusion 
of the decaying active tension in the estimation of diastolic biomarkers: the necessity of this 
model component was made clear when trying to find the evidence in real data of a better 
parameter identifiability by the use of sequential frames (Xi et al. 2013). 
The ultimate value of a diagnostic biomarker is provided when a correlation is found with 
clinical outcomes. Accordingly, clinical guidelines for the management of cardiac diseases 
are frequently based on indirect surrogates that render the needed predictive value to 
guide decisions. In this context, computational models bring the opportunity to improve 
existing biomarkers, and to propose novel ones, based on the fundamental mechanisms and 
physiological laws, rather than indirect surrogates.  
As outlined above, the long-term vision of the research community developing 
computational cardiac models is to inform clinical decisions based on personalized models 
with increasing levels of personalization, and eventually with the capability to predict the 
outcome of different treatment options. Initial evidence of the predictive capability of 
models has been provided in several clinical decision processes, such as the risk assessment 
of ventricular tachycardia1 , bone fracture(Schileo et al. 2008) or aneurysm rupture(Cebral 
 et al. 2005), or the patient selection for cardiac resynchronization therapy (Sermesant et al. 
2012; Niederer et al. 2010).   
We have argued, with demonstration cases, that the first step towards clinical translation is 
the explicative, and not the predictive, application of models, and that the adoption of novel 
model-based diagnostic biomarkers will be achieved through the adaptation of model 
complexity, assumptions and information relevant to the clinical context.  
Acknowledgements  
The authors would like to acknowledge funding from the Engineering and Physical Sciences 
Research Council (EP/G0075727/2), the Wellcome Trust Medical Engineering Centre at 
King’s College London (WT 088641/Z/09/Z). PL holds a Sir Henry Dale Fellowship funded 
jointly by the Wellcome Trust and the Royal Society (grant no. 099973/Z/12/Z). This 
research was supported by the National Institute for Health Research (NIHR) Biomedical 
Research Centre at Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London. 
The views expressed are those of the author(s) and not necessarily those of the NHS, the 
NIHR or the Department of Health. 
 References 
Al-Saadi, N. et al., 2000. Noninvasive detection of myocardial ischemia from perfusion 
reserve based on cardiovascular magnetic resonance. Circulation, 101(12), pp.1379–83. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/10736280 [Accessed July 13, 
2015]. 
Ashikaga, H. et al., 2013. Feasibility of image-based simulation to estimate ablation target in 
human ventricular arrhythmia. Heart Rhythm, 10, pp.1109–1116. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/23608593. 
Audoly, S. et al., 2001. Global identifiability of nonlinear models of biological systems. IEEE 
transactions on bio-medical engineering, 48(1), pp.55–65. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/11235592 [Accessed March 27, 2015]. 
Augenstein, K.F. et al., 2005. Method and Apparatus for Soft Tissue Material Parameter 
Estimation Using Tissue Tagged Magnetic Resonance Imaging. Journal of Biomechanical 
Engineering, 127(1), p.148. Available at: 
http://biomechanical.asmedigitalcollection.asme.org/article.aspx?articleid=1413659 
[Accessed January 31, 2015]. 
Bermejo, J. et al., 2013. Diastolic chamber properties of the left ventricle assessed by global 
fitting of pressure-volume data: improving the gold standard of diastolic function. 
Journal of applied physiology (Bethesda, Md. : 1985), 115(4), pp.556–68. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3742944&tool=pmcentrez
&rendertype=abstract [Accessed March 13, 2015]. 
Borlaug, B.A. & Paulus, W.J., 2011. Heart failure with preserved ejection fraction: 
pathophysiology, diagnosis, and treatment. Eur. Heart J., 32(6), pp.670–679. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/21138935. 
Butterworth, E. et al., 2013. JSim, an open-source modeling system for data analysis. 
F1000Research, 2, p.288. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3901508&tool=pmcentrez
&rendertype=abstract [Accessed July 13, 2015]. 
Cebral, J.R. et al., 2005. Characterization of Cerebral Aneurysms for Assessing Risk of 
Rupture By Using Patient-Specific Computational Hemodynamics Models. AJNR Am. J. 
Neuroradiol., 26(10), pp.2550–2559. Available at: 
http://www.ajnr.org/content/26/10/2550.short [Accessed July 13, 2015]. 
Chapelle, D. et al., 2010. A poroelastic model valid in large strains with applications to 
perfusion in cardiac modeling. Computational Mechanics, 46, pp.91–101. 
Clayton, R.H. et al., 2011. Models of cardiac tissue electrophysiology: progress, challenges 
and open questions. Progress in biophysics and molecular biology, 104(1), pp.22–48. 
Available at: http://www.sciencedirect.com/science/article/pii/S0079610710000362. 
 Cohn, J.N., Ferrari, R. & Sharpe, N., 2000. Cardiac remodeling-concepts and clinical 
implications: A consensus paper from an International Forum on Cardiac Remodeling. 
Journal of the American College of Cardiology, 35(3), pp.569–582. Available at: 
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0034162004&partnerID=40&md5=7f332d3759b09ee9231e1a14aeeb659b. 
Cookson, A.N. et al., 2012. A novel porous mechanical framework for modelling the 
interaction between coronary perfusion and myocardial mechanics. Journal of 
Biomechanics, 45(5), pp.850–855. 
Cookson, A.N. et al., 2014. A spatially-distributed computational model to quantify 
behaviour of contrast agents in MR perfusion imaging. Medical Image Analysis, 18(7), 
pp.1200–1216. 
Cookson, A.N. et al., 2015. Contrast Agent Transport In A Multiscale Poroelastic Model of 
Myocardial Perfusion. Journal of Computational Physics, Submitted. 
Cootes, T. et al., 1994. Use of active shape models for locating structures in medical images. 
Image and Vision Computing, 12(6), pp.355–365. Available at: 
http://www.sciencedirect.com/science/article/pii/0262885694900604 [Accessed 
March 30, 2015]. 
Cullen, J.H. et al., 1999. A myocardial perfusion reserve index in humans using first-pass 
contrast-enhanced magnetic resonance imaging. Journal of the American College of 
Cardiology, 33(5), pp.1386–94. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/10193743 [Accessed July 13, 2015]. 
DiFrancesco, D. & Noble, D., 1985. A model of cardiac electrical activity incorporating ionic 
pumps and concentration changes. Philos Trans R Soc Lond B Biol Sci, 307(1133), 
pp.353–398. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2578676. 
Fedak, P.W.M. et al., 2005. Cardiac remodeling and failure: from molecules to man (Part I). 
Cardiovascular pathology : the official journal of the Society for Cardiovascular 
Pathology, 14(1), pp.1–11. Available at: 
http://www.sciencedirect.com/science/article/pii/S1054880704007367 [Accessed 
March 23, 2015]. 
Finegold, J.A., Asaria, P. & Francis, D.P., 2013. Mortality from ischaemic heart disease by 
country, region, and age: statistics from World Health Organisation and United Nations. 
Int J Cardiol, 168(2), pp.934–945. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/23218570. 
Firstenberg, M.S. et al., 2000. Noninvasive estimation of transmitral pressure drop across 
the normal mitral valve in humans: Importance of convective and inertial forces during 
left ventricular filling. Journal of the American College of Cardiology, 36(6), pp.1942–
1949. Available at: http://www.scopus.com/inward/record.url?eid=2-s2.0-
0034669430&partnerID=40&md5=4b2d1c12ddeae67f5de3d0f0ff5489f5. 
 Fonseca, C.G. et al., 2011. The cardiac Atlas Project-an imaging database for computational 
modeling and statistical atlases of the heart. Bioinformatics, 27(16), pp.2288–2295. 
Available at: http://dx.doi.org/10.1093/bioinformatics/btr360. 
Gaddum, N.R. et al., 2015. Altered dependence of aortic pulse wave velocity on transmural 
pressure in hypertension revealing structural change in the aortic wall. Hypertension, 
65(2), pp.362–369. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25403607. 
Garny, A., Noble, D. & Kohl, P., 2005. Dimensionality in cardiac modelling. Progress in 
biophysics and molecular biology, 87(1), pp.47–66. Available at: 
http://www.scopus.com/inward/record.url?eid=2-s2.0-
4744346089&partnerID=tZOtx3y1 [Accessed March 28, 2015]. 
Gonzalez, G. et al., 2015. Improving the stratification power of cardiac ventricular shape. 
Journal of Cardiovascular Magnetic Resonance, 17(Suppl 1), p.O77. Available at: 
http://www.jcmr-online.com/content/17/S1/O77 [Accessed March 12, 2015]. 
Grenander, U. & Miller, M.I., 1998. Computational anatomy: An emerging discipline. 
Quarterly of Applied Mathematics, 56(4), pp.617–694. Available at: 
http://www.scopus.com/inward/record.url?eid=2-s2.0-
0032298437&partnerID=tZOtx3y1. 
Hadjicharalambous, M. et al., 2014. Analysis of passive cardiac constitutive laws for 
parameter estimation using 3D tagged MRI. Biomechanics and modeling in 
mechanobiology. Available at: http://link.springer.com/article/10.1007/s10237-014-
0638-9/fulltext.html [Accessed March 13, 2015]. 
Hautvast, G.L.T.F. et al., 2011. Quantitative analysis of transmural gradients in myocardial 
perfusion magnetic resonance images. Magn Reson Med, 66(5), pp.1477–1487. 
Heimann, T. & Meinzer, H.-P., 2009. Statistical shape models for 3D medical image 
segmentation: A review. Medical Image Analysis, 13(4), pp.543–563. Available at: 
http://www.scopus.com/inward/record.url?eid=2-s2.0-
70349090032&partnerID=40&md5=944bf1f2c4aff61a845d6f1e508400ec. 
Helm, P.A. et al., 2006. Evidence of structural remodeling in the dyssynchronous failing 
heart. Circ. Res., 98(1), pp.125–132. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/16339482. 
Hunter, P.J. & Borg, T.K., 2003. Integration from proteins to organs: the Physiome Project. 
Nat Rev Mol Cell Biol, 4(3), pp.237–243. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12612642. 
Hyde, E.R. et al., 2014. Multi-scale parameterisation of a myocardial perfusion model using 
whole-organ arterial networks. Ann Biomed Eng, 42(4), pp.797–811. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/24297493. 
 Hyde, E.R. et al., 2012. Parameterisation of multi-scale continuum perfusion models from 
discrete vascular networks. Medical & Biological Engineering & Computing, 51(5), 
pp.557–570. 
Ishida, M. et al., 2010. Quantitative assessment of myocardial perfusion MRI. Current 
Cardiovascular Imaging Reports, 3(2), pp.65–73. 
Jerosch-Herold, M. et al., 2004. Analysis of myocardial perfusion MRI. Journal of magnetic 
resonance imaging : JMRI, 19(6), pp.758–70. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15170782 [Accessed July 13, 2015]. 
Jerosch-Herold, M., Wilke, N. & Stillman, A.E., 1998. Magnetic resonance quantification of 
the myocardial perfusion reserve with a Fermi function model for constrained 
deconvolution. Medical Physics, 25(1), pp.73–84. 
Kirk, J.A., Saccomani, M.P. & Shroff, S.G., 2013. A Priori Identifiability Analysis of 
Cardiovascular Models. Cardiovascular Engineering and Technology, 4(4), pp.500–512. 
Available at: http://link.springer.com/10.1007/s13239-013-0157-3 [Accessed March 
27, 2015]. 
Lamata, P. et al., 2011. An accurate, fast and robust method to generate patient-specific 
cubic Hermite meshes. Medical image analysis, 15(6), pp.801–813. Available at: 
http://www.sciencedirect.com/science/article/pii/S1361841511000971. 
Lamata, P., Sinclair, M., et al., 2014. An automatic service for the personalization of 
ventricular cardiac meshes. Journal of The Royal Society Interface, 11(91). Available at: 
http://rsif.royalsocietypublishing.org/content/11/91/20131023.abstract. 
Lamata, P., Pitcher, A., et al., 2014. Aortic relative pressure components derived from four-
dimensional flow cardiovascular magnetic resonance. Magnetic Resonance in Medicine, 
72(4), pp.1162–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24243444. 
Lamata, P., Casero, R., et al., 2014. Images as drivers of progress in cardiac computational 
modelling. Progress in biophysics and molecular biology, 115(2-3), pp.198–212. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4210662&tool=pmcentrez
&rendertype=abstract [Accessed December 24, 2014]. 
Lee, J. et al., 2014. In silico Coronary Wave Intensity Analysis: Application of an Integrated 
One-dimensional and Poromechanical Model of Cardiac Perfusion. Journal of 
Physiology, Under revi. 
Lewandowski, A.J. et al., 2013. Preterm heart in adult life: cardiovascular magnetic 
resonance reveals distinct differences in left ventricular mass, geometry, and function. 
Circulation, 127, pp.197–206. Available at: 
http://dx.doi.org/10.1161/CIRCULATIONAHA.112.126920. 
 Li, L. et al., 2010. A mathematical model of the murine ventricular myocyte: a data-driven 
biophysically based approach applied to mice overexpressing the canine NCX isoform. 
American journal of physiology. Heart and circulatory physiology, 299(4), pp.H1045–63. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/20656884 [Accessed March 27, 
2015]. 
Maeder, M.T. & Kaye, D.M., 2009. Heart Failure With Normal Left Ventricular Ejection 
Fraction. Journal of the American College of Cardiology, 53(11), pp.905–918. Available 
at: http://www.scopus.com/inward/record.url?eid=2-s2.0-
61549090009&partnerID=40&md5=aea626f3a265f46870dee68ee0d838e8. 
Medrano-Gracia, P. et al., 2013. Atlas-based analysis of cardiac shape and function: 
correction of regional shape bias due to imaging protocol for population studies. 
Journal of Cardiovascular Magnetic Resonance, 15(1), p.80. Available at: 
http://dx.doi.org/10.1186/1532-429X-15-80. 
Members, A.F. et al., 2012. ESC Guidelines for the diagnosis and treatment of acute and 
chronic heart failure 2012. European Journal of Heart Failure, 14(8), pp.803–869. 
Available at: http://dx.doi.org/10.1093/eurjhf/hfs105. 
Michler, C. et al., 2013. A computationally efficient framework for the simulation of cardiac 
perfusion using a multi-compartment Darcy porous-media flow model. International 
Journal for Numerical Methods in Biomedical Engineering, 29(2), pp.217–232. Available 
at: http://dx.doi.org/10.1002/cnm.2520. 
Min, J.K. et al., 2012. Diagnostic accuracy of fractional flow reserve from anatomic CT 
angiography. Jama, 308(12), pp.1237–1245. Available at: 
http://archinte.jamanetwork.com/article.aspx?articleid=1352969. 
Morris, P.D. et al., 2013. Virtual fractional flow reserve from coronary angiography: 
modeling the significance of coronary lesions: results from the VIRTU-1 (VIRTUal 
Fractional Flow Reserve From Coronary Angiography) study. JACC. Cardiovascular 
interventions, 6(2), pp.149–57. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/23428006 [Accessed July 7, 2015]. 
Motwani, M. et al., 2014. Quantitative three-dimensional cardiovascular magnetic 
resonance myocardial perfusion imaging in systole and diastole. Journal of 
Cardiovascular Magnetic Resonance, 16. 
Nagel, E. et al., 2003. Magnetic resonance perfusion measurements for the noninvasive 
detection of coronary artery disease. Circulation, 108(4), pp.432–7. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12860910 [Accessed July 13, 2015]. 
Nasopoulou, A. et al., 2015. Myocardial Stiffness Estimation: A Novel Cost Function for 
Unique Parameter Identification. In H. van Assen, P. Bovendeerd, & T. Delhaas, eds. 
Functional Imaging and Modeling of the Heart SE  - 41. Lecture Notes in Computer 
Science. Springer International Publishing, pp. 355–363. Available at: 
http://dx.doi.org/10.1007/978-3-319-20309-6_41. 
 Niederer, S.A. et al., 2009. A meta-analysis of cardiac electrophysiology computational 
models. Exp Physiol, 94(5), pp.486–495. Available at: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cit
ation&list_uids=19139063. 
Niederer, S.A. et al., 2010. Length-dependent tension in the failing heart and the efficacy of 
cardiac resynchronization therapy. Cardiovascular research, 89(2), pp.336–343. 
Available at: http://cardiovascres.oxfordjournals.org/content/89/2/336.short 
[Accessed November 26, 2010]. 
Nolte, F. et al., 2013. Myocardial perfusion distribution and coronary arterial pressure and 
flow signals: clinical relevance in relation to multiscale modeling, a review. Medical & 
Biological Engineering & Computing, 51(11), pp.1271–1286. 
Opie, L.H. et al., 2006. Controversies in ventricular remodelling. Lancet, 367(9507), pp.356–
367. Available at: http://www.scopus.com/inward/record.url?eid=2-s2.0-
31444448021&partnerID=40&md5=ceaf1b4711baa212c56abac7540bccfd. 
Pathmanathan, P. & Gray, R.A., 2013. Ensuring reliability of safety-critical clinical 
applications of computational cardiac models. Frontiers in physiology, 4, p.358. 
Available at: 
http://www.researchgate.net/publication/259492583_Ensuring_reliability_of_safety-
critical_clinical_applications_of_computational_cardiac_models [Accessed July 9, 
2015]. 
Rappaport, D. et al., 2007. Detection of the cardiac activation sequence by novel 
echocardiographic tissue tracking method. Ultrasound Med Biol, 33(6), pp.880–893. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/17445969. 
Relan, J. et al., 2011. Coupled personalization of cardiac electrophysiology models for 
prediction of ischaemic ventricular tachycardia. Interface focus, 1(3), pp.396–407. 
Available at: http://www.scopus.com/inward/record.url?eid=2-s2.0-
80053586233&partnerID=tZOtx3y1 [Accessed March 27, 2015]. 
Schileo, E. et al., 2008. Subject-specific finite element models implementing a maximum 
principal strain criterion are able to estimate failure risk and fracture location on 
human femurs tested in vitro. Journal of biomechanics, 41(2), pp.356–67. Available at: 
http://www.jbiomech.com/article/S0021929007003752/fulltext [Accessed July 13, 
2015]. 
Sermesant, M. et al., 2006. Cardiac function estimation from MRI using a heart model and 
data assimilation: advances and difficulties. Med Image Anal, 10(4), pp.642–656. 
Available at: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cit
ation&list_uids=16765630. 
Sermesant, M. et al., 2012. Patient-specific electromechanical models of the heart for the 
prediction of pacing acute effects in CRT: A preliminary clinical validation. Medical 
 Image Analysis, 16(1), pp.201–215. Available at: 
http://www.sciencedirect.com/science/article/pii/S1361841511001009. 
Shi, W. et al., 2012. A comprehensive cardiac motion estimation framework using both 
untagged and 3-D tagged MR images based on nonrigid registration. IEEE Trans Med 
Imaging, 31(6), pp.1263–75. 
Smith, N. et al., 2011. euHeart: personalized and integrated cardiac care using patient-
specific cardiovascular modelling. Interface Focus, 1(3), pp.349–364. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22670205. 
Smith, N.P., 2004. A computational study of the interaction between coronary blood flow 
and myocardial mechanics. Physiol Meas, 25(4), pp.863–877. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15382827. 
Smith, N.P. et al., Computational Biology of Cardiac Myocytes: Proposed Standards for the 
Physiome. Journal of Experimental Biology, pp.1576–1583. 
Sourbron, S., 2014. A Tracer-Kinetic Field Theory for Medical Imaging. IEEE Transactions on 
Medical Imaging, 33(4), pp.935–946. 
Spaan, J.A., Breuls, N.P. & Laird, J.D., 1981. Diastolic-systolic coronary flow differences are 
caused by intramyocardial pump action in the anesthetized dog. Circ Res, 49(3), 
pp.584–593. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7261259. 
Tofts, P.S. et al., 1999. Estimating kinetic parameters from dynamic contrast-enhanced T1-
weighted MRI of a diffusable tracer: Standardized quantities and symbols. Journal of 
Magnetic Resonance Imaging, 10(3), pp.223–232. 
Wang, V.Y. et al., 2009. Modelling passive diastolic mechanics with quantitative MRI of 
cardiac structure and function. Medical Image Analysis, 13(5), pp.773–784. Available 
at: http://www.sciencedirect.com/science/article/B6W6Y-4WSHK8S-
1/2/b4ea8ffba695d1d2f941db069cd88ef8. 
Winslow, R.L. et al., 2012. Computational medicine: translating models to clinical care. 
Science translational medicine, 4(158), p.158rv11. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3618897&tool=pmcentrez
&rendertype=abstract [Accessed March 28, 2015]. 
Wong, K.C.L. et al., 2015. Velocity-based cardiac contractility personalization from images 
using derivative-free optimization. Journal of the mechanical behavior of biomedical 
materials, 43, pp.35–52. Available at: 
http://www.sciencedirect.com/science/article/pii/S1751616114003816 [Accessed 
March 23, 2015]. 
Xi, J. et al., 2011. Myocardial transversely isotropic material parameter estimation from in-
silico measurements based on a reduced-order unscented Kalman filter. Journal of the 
 mechanical behavior of biomedical materials, 4(7), pp.1090–1102. Available at: 
http://www.sciencedirect.com/science/article/pii/S1751616111000634. 
Xi, J. et al., 2013. The estimation of patient-specific cardiac diastolic functions from clinical 
measurements. Medical image analysis, 17(2), pp.133–146. Available at: 
http://www.scopus.com/inward/record.url?eid=2-s2.0-
84868578798&partnerID=40&md5=58d4231086733051f39a8ebba43cc561. 
Xi, J. et al., 2014. Understanding the need of ventricular pressure for the estimation of 
diastolic biomarkers. Biomechanics and Modeling in Mechanobiology, 13, pp.747–757. 
Available at: http://dx.doi.org/10.1007/s10237-013-0531-y. 
Zierler, K.L., 1962. Theoretical Basis of Indicator-Dilution Methods For Measuring Flow and 
Volume. Circulation Research, 10, pp.393–407. 
 
 Figure Captions  
Fig. 1: Conceptual diagram illustrating how the field of computational modelling interacts 
with experimental physiologists and the field of biomedical signal analysis. Laws, models of 
our understanding of physiology are built from experimental data (vertical orange arrow), 
and these models are used to interpret clinical data and reveal novel personalized 
biomarkers (horizontal blue arrow). 
Fig. 2: Personalization of anatomical models using computational meshes with high order 
interpolation (Lamata, Sinclair, et al. 2014; Lamata et al. 2011). (a) Segmentation of a stack 
of short axis slices of the left ventricle, showing an acquisition limitation, a slice shift. (b) The 
reconstructed smooth geometry of the left ventricle, which has been implicitly regularized 
to the template shape of a truncated ellipsoid, reducing the impact of acquisition and 
segmentation errors.  
Fig. 3: Personalization results of mechanical models to reveal the parameters of decaying 
active tension and myocardial stiffness. Three instants of diastolic filling phase are shown, 
and illustrate the good match found between the simulated meshes and the original 
medical images.  
Fig. 4: Anatomically based model from (Smith 2004) computing blood flow within a coupled 
model of coronary flow and large deformation myocardial contraction. The colour coding 
shows the force of compression on the embedded coronaries during diastole (left) and mid 
systole (right) ranging from blue (0 KPa) to red (10 KPa).   
Fig. 5: Simulation setup used in (Cookson et al. 2014), to model the passage of CA through 
the capillaries. The permeability tensor K can be made spatially heterogeneous to simulate a 
 regional perfusion defect. Contrast agent diffuses from the blood into the tissue, and vice 
versa, at a rate proportional to the concentration difference that exists between the two 
phases. Originally published in (Cookson et al. 2014), reproduced here in modified form 
under the Creative Commons License 3.0 (http://creativecommons.org/licenses/by/3.0/). 
Fig. 6: a 2D perfusion image of the mid-third of the heart exhibiting a perfusion defect 
(indicated by arrows) (a), with time series extracted in healthy and defect regions (b), 
simulated time series data for a blood-bound contrast agent in both healthy and diseased 
regions (c), simulated time series data for a freely-diffusing contrast agent in both healthy 
and diseased regions (d), concentration contour plots taken at several time points for the 
freely-diffusing contrast agent (e). For data sampled in the healthy region of the 
myocardium, dashed dark blue represents the contribution to the signal from the fluid, 
dashed green represents the contribution from the tissue and the solid light blue curve is 
the total, observed signal. In the defect region, total signal is shown by the solid red line. 
Fig. 7: The variation of signal upslope with Da and Pe illustrating the behaviour of perfusion 
reserve index for three indicative contrast agents, which have varying degrees of freely-
diffusing behaviour. CAs in Zone 2 are most sensitive to changes in velocity and therefore 
most suited for use with the perfusion reserve index, whereas CAs in Zone 3 are unsuited to 
this metric due to the upslope varying only slightly with changes in velocity. Originally 
published in (Cookson et al. 2014), reproduced here in modified form under the Creative 
Commons License 3.0 (http://creativecommons.org/licenses/by/3.0/). 
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